Local recurrence and residual tumor rates following cryoablation for small early-stage breast cancers: systemic review and meta-analysis
Breast Cancer · 2025
DOI: 10.1007/s12282-024-01643-w ↗Kurz gefasst
Metaanalyse in der Zeitschrift Breast Cancer, 2025. Verfasst von Eelin Tan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Radiology, Tan Tock Seng Hospital, Singapore, Singapore. eelinnn@gmail.com. Hauptthemen laut MEDLINE: Cryosurgery, Breast Neoplasms, Neoplasm Recurrence, Local, Neoplasm, Residual. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 64 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Cryoablation is currently being investigated as a minimally invasive alternative to breast-conserving surgery. This meta-analysis investigates the local recurrence and residual tumor rates after cryoablation for small early-stage breast cancers. METHODS: A systematic search was conducted on Embase, PubMed, Google Scholar, and the International Clinical Trials Registry Platform from inception to 16 June 2024. Studies of patients with breast cancers ≤ 20 mm treated with cryoablation only or cryoablation followed by surgery were included. Pooled local recurrence rates (cryoablation only) and pooled residual tumors rates (cryoablation followed by surgery) were estimated with mixed-effects models. Between-study heterogeneity was assessed using I2 statistics. Where I2 exceeded 50%, outlier and influence analysis, followed by sensitivity analysis excluding outliers, were conducted. RESULTS: Twelve studies met inclusion criteria, of which 7 studies (530 female patients, 531 breast tumors) reported on patients treated with cryoablation only and 5 studies (220 female patients, 222 breast tumors) reported on patients treated with cryoablation followed by surgery. For studies on cryoablation only, pooled local recurrence rate was 1.1% (95% CI 0.42-3.03%) with low between-study heterogeneity (I2 value = 0%; 95% CI 0.0-70.8%; p = 0.95). For studies on cryoablation followed by surgery, pooled residual tumor rate was 12.0% (95% CI 3.85-31.64%); however, substantial between-study heterogeneity (I2 value = 76.1%; 95% CI 41.7-90.2%; p < 0.01) was present. Influence analysis revealed 1 outlier study. When this study was excluded, pooled residual tumor rate was 8.2% (95% CI 3.84-16.68%) with improvement in heterogeneity (I2 value = 0%; 95% CI 0.0-84.7%; p = 0.64). CONCLUSION: Pooled local recurrence and residual tumor rates after cryoablation are comparable to local recurrence rates after breast-conserving therapy and re-excision rates following breast-conserving surgery, respectively. These results are encouraging but should be interpreted with caution due to lack of comparative studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Diagnostic Radiology, Tan Tock Seng Hospital, Singapore, Singapore. eelinnn@gmail.com.
- Department of Diagnostic Radiology, Tan Tock Seng Hospital, Singapore, Singapore.
- Department of Breast and Endocrine Surgery, Tan Tock Seng Hospital, Singapore, Singapore.
- Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
Zitieren
APA
Tan, E., Chong, J., Pua, U., Tan, E. Y., & Mok, W. Y. (2025). Local recurrence and residual tumor rates following cryoablation for small early-stage breast cancers: systemic review and meta-analysis. Breast Cancer. https://doi.org/10.1007/s12282-024-01643-w
Vancouver
Tan E, Chong J, Pua U, Tan EY, Mok WY. Local recurrence and residual tumor rates following cryoablation for small early-stage breast cancers: systemic review and meta-analysis. Breast Cancer. 2025. doi:10.1007/s12282-024-01643-w
BibTeX
@article{Tan2025,
author = {Tan, Eelin and Chong, Jingli and Pua, Uei and Tan, Ern Yu and Mok, Wing Yan},
title = {Local recurrence and residual tumor rates following cryoablation for small early-stage breast cancers: systemic review and meta-analysis},
journal = {Breast Cancer},
year = {2025},
doi = {10.1007/s12282-024-01643-w}
}
EUVIMED